Join Growin Stock Community!
Beta
Back to RXRX.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
net-income-chart

RXRX Net Income

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for RXRX's net income in Q1'26 shows a loss of $117.5M USD, marking a slight increase in losses compared to the previous quarter's $108.1M USD deficit in Q4'25, though it represents an improvement from the peak loss of $202.5M USD in Q1'25. Over the period from Q2'23 to Q1'26, net income has exhibited a volatile yet generally deepening trend of losses, starting at $76.7M USD in Q2'23 and escalating to a high of $202.5M USD in Q1'25 before partial recovery to $108.1M USD in Q4'25. Year-over-year changes highlight significant deterioration, with declines exceeding 50% in most quarters until Q4'25 and Q1'26, where positive YoY growth of 39.6% and 42.0% respectively indicates emerging stabilization amid ongoing negative profitability. This bar and line chart pattern suggests persistent operational challenges, with no quarters achieving positive net income.